Surveying Recent Trial Updates for R/R Lymphoma Management

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

Surveying Recent Trial Updates for R/R Lymphoma Management

By UNC Lineberger Comprehensive Cancer Center FEATURING Anne Beaven

55 views

October 21, 2021

0 Comments

ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…

Feat. D. Tremblay

Safety Profile of Ruxolitinib in Patients With MF

Feat. D. Tremblay

CAR T-Cell vs. Bispecific Therapies for Blood Cancers: How Oncologis…

Feat. A. Goodman, A. Jeong, S. Rajeeve

13:07

Moffitt Cancer Center

R/R DLBCL: Are Bispecific Antibodies Superior to CAR-T?

Feat. J. Chavez

45:56

Yale Cancer Center

Endocrine Adverse Events From Checkpoint Inhibitors

Feat. K. Herold

09:18

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Primary OS Analysis of the Phase 3 Random…

Feat. J. Westin

06:33

Christopher Flowers

FDA Approval of Zanubrutinib in R/R FL: What You Need to Know

10:04

Tara Graff

How to Incorporate Bispecific Antibodies Into Your NHL Practice: A P…

20:18

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

Will Immune Therapy Replace Transplant in Hematologic Malignancies?

Feat. R. Gale

08:23

Total Health

R/R DLBCL Case Discussion: 81 y/o Male Needing 3rd Line Treatment

Feat. J. Chandler, B. Randolph, M. Onciu

13:56

SOHO 2023 Eleventh Annual Meeting

Follicular Lymphoma Management: What Is the New Order?

Feat. B. Kahl

08:51

Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Outpatient Management of CAR-T and Bi-Speci…

Feat. R. Bansal

04:08

GRACE

CAR T-Cell Therapy Side Effects for Blood Cancers

Feat. A. Goodman

62:02

UChicago Medicine

New Treatment Strategies in DLBCL

Feat. L. Sehn

09:45

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Therapeutic Options for Pts With Primary …

Feat. M. Kamdar

16:03

SOHO 2023 Eleventh Annual Meeting

SOHO 2023: The New Algorithm for 2L LBCL

Feat. J. Westin

15:26

Moffitt Cancer Center

R/R DLBCL: Are CAR-Ts Superior to Bispecific Antibodies?

Feat. A. Lazaryan

32:52

Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies

The Improbable History of CAR T-Cells

Feat. C. June

27:51

Louisville Hematology Highlights

Summary of Recent Advances in Follicular Lymphoma

Feat. S. Gaballa

15:24

Michael Soulen

Interventional Delivery of CAR-T Therapy

19:46

Scripps MD Anderson Cancer Center Clinical Hematology & Oncology 2024

Management of Indolent NHL

Feat. E. Brem

17:21

Daniel Addison

Login

Login

Join VuMedi

Surveying Recent Trial Updates for R/R Lymphoma Management

Related Content